invIOs to attend JP Morgan Week in San Francisco in January

CARBIOS has received €1.2M of the €11.4M granted by ADEME to further optimize its unique PET depolymerization process and guarantee its competitiveness

iOmx Therapeutics attends 2024 J.P. Morgan Healthcare Conference

Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood

Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site

Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees

Carbios praised by French President at two-year anniversary of France 2030

Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board

Affluent Medical: Start of the European Pilot Study with the Artus Medical Device for the Treatment of Urinary Incontinence

New appointment to Carbios’ Executive Committee to Secure Rapid Growth of its Organization and Operations